Adenoviral vector-mediated overexpression of IL-4 in the knee joint of mice with collagen-induced arthritis prevents cartilage destruction

Journal of Immunology

Volumn 163, Issue 8, 1999, Pages 4546-4556

  Lubberts, Erik ^a   Joosten, Leo A B ^a   Van Den Bersselaar, Liduine ^a   Helsen, Monique M A ^a   Bakker, Andrew C ^a   Van Meurs, Joyce B J ^a   Graham, Frank L ^b   Richards, Carl D ^b   Van Den Berg, Wim B ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; INTERLEUKIN 1BETA; INTERLEUKIN 4; PROTEOGLYCAN; STROMELYSIN; TUMOR NECROSIS FACTOR ALPHA; VIRUS VECTOR;

ADENOVIRUS 5; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DESTRUCTION; CARTILAGE CELL; CARTILAGE DEGENERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE THERAPY; INTRAARTICULAR DRUG ADMINISTRATION; KNEE ARTHRITIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVITIS; VIRUS RECOMBINANT;

EID: 0032853313     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Firestein, G. S., J. M. Alvaro-Garcia, and R. Maki. 1990. Quantitative analysis of cytokine gene expression in rheumatoid arthritis. J. Immunol. 144:3347.
2. Chen, E., E. C. Keystone, and E. N. Fish. 1993. Restricted cytokine expression in rheumatoid arthritis. Arthritis Rheum. 36:901.
3. Arend, W. P., and J.-M. Dayer. 1995. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor α in rheumatoid arthritis. Arthritis Rheum. 38:151.
4. Feldmann, M., M. J. Elliot. J. N. Woody, and R. N. Maini. 1997. Anti-tumor necrosis factor-α therapy of rheumatoid arthritis. Adv. Immunol. 64:283.
5. Elliot, M. J., R. N. Maini, M. Feldmann, J. R. Kalden, C. Antoni, J. Smolen, B. Leeb, F. C. Breedveld, J. D. Macfarlane, H. Bijl, and J. N. Woody. 1994. Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor α (cA2) versus placebo in rheumatoid arthritis. Lancet 344:1105.
6. Rankin, E. C. C., E. H. S. Choy, D. Kassimos, G. H. Kingsley, A. M. Sopwith, D. A. Isenberg, and G. S. Panayi. 1995. The therapeutic effects of an engineered human anti-tumor necrosis factor α antibody (CDP571) in rheumatoid arthritis. Br. J. Rheumatol. 34:334.
7. Chomarat, P., and J. Banchereau. 1997. An update on interleukin-4 and its receptor. Eur. Cytokine Netw. 8:333.
8. Miossec, P., J. Briolay, J. Dechanet, J. Wijdenes, H. Martinez-Valdez, and J. Banchereau. 1992. Inhibition of the production of proinflammatory cytokines and immunoglobulins by interleukin-4 in an ex vivo model of rheumatoid synovitis. Arthritis Rheum. 35:874.
9. Chomarat, P., E. Vannier, J. Dechanet, M. C. Rissoan, J. Banchereau, C. A. Dinarello, and P. Miossec. 1995. Balance of IL-1 receptor antagonist/IL-1β in rheumatoid synovium and its regulation by IL-4 and IL-10. J. Immunol. 154: 1432.
10. Colotta, F., F. Re, M. Muzio, R. Bertini, N. Polentarutti, M. Sironi, S. K. Dower, J. E. Sims, and A. Mantovani. 1993. Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science 261:472.
11. Cope, A. P., D. L. Gibbons, and D. Aderka. 1993. Differential regulation of tumor necrosis factor receptors (TNF-R) by IL-4: up-regulation of p55 and p75 TNF-R on synovial joint mononuclear cells. Cytokine 3:205.
12. O'Garra, A. 1998. Cytokines induce the development of functionally heterogenous T helper cell subsets. Immunity 8:275.
13. Miossec, P., and W. B. van den Berg. 1997. Th1/Th2 cytokine balance in arthritis. Arthritis Rheum. 40:2105.
14. Yen, L.-A., A. J. Augustine, P. Lee, L. S. Riviere, and A. Sheldon. 1995. Interleukin-4, an inhibitor of cartilage breakdown in bovine articular cartilage explants. J. Rheumatol. 22:1740.
15. Shingu, M., S. Miyauchi, Y. Nagai, C. Yasutake, and K. Horie. 1995. The role of IL-4 and IL-6 in IL-1-dependent cartilage matrix degradation. Br. J. Rheumatol. 34:101.
16. Van Roon, J. A. G., J. L. A. M. van Roy, F. H. J. Gmelig-Meyling, F. P. J. G. Lafeber, and J. W. J. Bijlsma. 1996. Prevention and reversal of cartilage degradation in rheumatoid arthritis by interleukin-10 and interleukin-4. Arthritis Rheum. 39:829.
17. Cawston, T. E., A. J. Ellis, H. Bigg, V. Curry, E. Lean, and D. Ward. 1996. Interleukin-4 blocks the release of collagen fragments from bovine nasal cartilage treated with cytokines. Biochim. Biophys. Acta 1314:226.
18. Odeh, M. 1997. New insights into the pathogenesis and treatment of rheumatoid arthritis. Clin. Immunol. Immunopathol. 83:103.
19. Allen, J. B., H. L. Wong, G. L. Costa, M. J. Bienkowski, and S. M. Wahl. 1993. Suppression of monocyte function and differential regulation of IL-1 and IL-1ra by IL-4 contribute to resolution of experimental arthritis. J. Immunol. 151:4344.
20. Joosten, L. A. B., E. Lubberts, P. Durez, M. M. A. Helsen, M. J. M. Jacobs, M. Goldman, and W. B. van den Berg. 1997. Role of interleukin-4 and inlerleukin-10 in murine collagen-induced arthritis: protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction. Arthritis Rheum. 40:249.
21. Roessler, B. J., E. D. Allen, J. M. Wilson, J. W. Hartman, and B. L. Davidson. 1993. Adenoviral-mediated gene transfer to rabbit synovium in vivo. J. Clin. Invest. 92:1085.
22. Roessler, B. J., J. W. Hartman, D. K. Vallance, J. M. Latta, S. L. Janich, and B. L. Davidson. 1995. Inhibition of interleukin-1 induced effects in synoviocytes transduced with the human IL-1 receptor antagonist cDNA using an adenoviral vector. Hum. Gene Ther. 6:307.
23. Nita, I., S. C. Ghivizzani, J. Galea-Lauri, G. Bandara, H. I. Georgescu, P. D. Robbins, and C. H. Evans. 1996. Direct gene delivery to synovium: an evaluation of potential vectors in vitro and in vivo. Arthritis Rheum. 39:820.
24. Sawchuk, S. J., G. P. Boivin, L. E. Duwel, W. Ball, K. Bove, B. Trapnell, and R. Hirsch. 1996. Anti-T cell receptor monoclonal antibody prolongs transgene expression following adenovirus-mediated in vivo gene transfer to mouse synovium. Hum. Gene Ther. 7:499.
25. Ghivizzani, S. C., E. R. Lechman, R. Kang, C. Tio, J. Kolls, C. H. Evans, and P. D. Robbins. 1998. Direct adenovirus-mediated gene transfer of interleukin I and tumor necrosis factor α soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effects. Proc. Natl. Acad. Sci. USA 95:4613.
26. Hogaboam, C. M., B. A. Vallance, A. Kumar, C. L. Addison, F. L. Graham, J. Gauldie, and S. M. Collins. 1997. Therapeutic effects of interleukin-4 gene transfer in experimental inflammatory bowel disease. J. Clin. Invest. 100:2766.
27. Xing, Z., Y. Ohkawara, M. Jordana, F. L. Graham, and J. Gauldie. 1996. Transfer of GM-CSF gene to rat lung induces eosinophilia, monocytosis and fibrotic reactions. J. Clin. Invest. 97:1102.
28. Lubberts, E., L. A. B. Joosten, M. M. A. Helsen, and W. B. van den Berg. 1998. Regulatory role of interleukin-10 in joint inflammation and cartilage destruction in murine streptococcal cell wall (SCW) arthritis: more therapeutic benefit with IL-4/IL-10 combination therapy than with IL-10 treatment alone. Cytokine 10: 361.
29. Van Meurs, J. B. J., P. L. E. M. van Lent, L. A. B. Joosten, P. M. van der Kraan, and W. B. van den Berg. 1997. Quantification of mRNA levels in joint capsule and articular cartilage of the murine knee joint by RT-PCR. Rheumatol. Int. 16:197.
30. Chomczynski, P., and N. Sacchi. 1987. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156.
31. Van den Berg, W. B., L. A. B. Joosten, and L. B. A. van de Putte. 1984. Electrical charge of the antigen determines intraarticular handling and chronicity of arthritis in mice. J. Clin. Invest. 74:1850.
32. Van den Berg, W. B., H. J. van Beusekom, L. B. A. van de Putte, W. A. Zwarts, and M. van der Sluis. 1982. Antigen handling in antigen-induced arthritis in mice: an autoradiographic and immunofluorescence study using whole joint sections. Am. J. Pathol. 108:9.
33. Van Meurs, J. B. J., P. L. E. M. van Lent, I. I. Singer, E. K. Bayne, F. A. J. van de Loo, and W. B. van den Berg. 1998. Interleukin-1 receptor antagonist prevents expression of the metalloproteinase-generated neoepitope VDIPEN in antigen-induced arthritis. Arthritis Rheum. 41:647.
34. Van Meurs, J. B. J., P. L. E. M. van Lent, A. E. M. Holthuysen, R. Stoop, I. Singer, E. K. Bayne, D. Visco, J. S. Mudgett, and W. B. van den Berg. 1998. Expression of the MMP-induced neoepitope FVDIPEN is linked to severe cartilage damage: an essential role for stromelysin in antigen-induced arthritis. Trans 44th Orthop. Res. Soc. 23:856 (Abstr.).
35. Singer, I. I., D. W. Kawka, E. K. Bayne, A. A. Donatelli, J. R. Weidner, H. R. Williams, J. M. Ayala, R. A. Mumford, M. W. Lark, T. T. Giant, et al. 1995. VDIPEN, a metalloproteinase-generated neoepitope, is induced and immunolocalized in articular cartilage during inflammatory arthritis. J. Clin. Invest. 95: 2178.
36. Van den Berg, W. B., L. A. B. Joosten, M. M. A. Helsen, and A. J. J. van de Loo. 1994. Amelioration of established murine collagen-induced arthritis with anti-IL-1 treatment. Clin. Exp. Immunol. 11:237.
37. Joosten, L. A. B., M. M. A. Helsen, F. A. J. Van de Loo, and W. B. Van den Berg. 1996. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice: a comparative study using anti-TNFα, anti-IL-1αβ, and IL-1Ra. Arthritis Rheum. 39:797.
38. Bakker, A. C., L. A. B. Joosten, O. J. Arntz, M. M. A. Helsen, A. M. Bendele, F. A. J. Van de Loo, and W. B. Van den Berg. 1997. Prevention of murine collagen-induced arthritis in the knee and ipsilateral paw by local expression of human interleukin-1 receptor antagonist protein in the knee. Arthritis Rheum. 40:893.
39. Van de Loo, F. A. J., L. A. B. Joosten, P. L. E. M. van Lent, O. J. Arntz, and W. B. van den Berg. 1995. Role of Interleukin-1, tumor necrosis factor α, and interleukin-6 in cartilage proteoglycan metabolism and destruction: effect of in situ blocking in murine antigen- and zymosan-induced arthritis. Arthritis Rheum. 38:164.
40. Van de Loo, F. A. J., O. J. Arntz, F. H. J. van Enckevort, P. L. E. M. van Lent, and W. B. van den Berg. 1998. Reduced cartilage proteoglycan loss during zymosan-induced gonarthritis in NOS2-defident mice and in anti-interleukin-1-treated wild-type mice with unabated joint inflammation. Arthritis Rheum. 41:634.
41. Trentham, D. E., A. S. Townes, and A. H. Kang. 1977. Autoimmunity to type II collagen: an experimental model of arthritis. J. Exp. Med. 146:857.
42. Courtenay, J. S., M. J. Dallman, A. B. Dayan, A. Martin, and B. Mosedale. 1980. Immunization against heterologous type II collagen-induced arthritis in mice. Nature 2843:666.
43. Stuart, J. M., A. S. Townes, and A. H. Kang. 1982. Nature and specificity of immune responses to collagen in type II collagen-induced arthritis in mice. J. Clin. Invest. 69:673.
44. Myers, L. K., E. F. Rosloniec, M. A. Cremer, and A. H. Kang. 1997. Collagen-induced arthritis, an animal model of autoimmunity. Life Sci. 61:1861.
45. Joosten, L. A. B., E. Lubberts, M. M. A. Helsen, and W. B. van den Berg. 1997. Dual role of IL-12 in early and late stages of murine collagen type II arthritis. J. Immunol. 159:4094.
46. Lacraz, S., L. Nicod, B. Galve-de Rochemonteix, C. Baumberger, J.-M. Dayer, and H. G. Welgus. 1992. Suppression of metalloproteinase biosynthesis in human alveolar macrophages by interleukin-4. J. Clin. Invest. 90:382.
47. Prontera, C., G. Crescenzi, and D. Rotilio. 1996. Inhibition by interleukin-4 of stromelysin expression in human skin fibroblasts: role of PKC. Exp. Cell Res. 224:183.
48. Hiester, A. A., D. R. Metcalf, and P. A. Campbell. 1992. Interleukin-4 is chemotactic for mouse macrophages. Cell. Immunol. 139:72.
49. Postlethwaite, A. E., and J. M. Seyer. 1991. Fibroblast chemotaxis induction by human recombinant interleukin-4. J. Clin. Invest. 87:2147.
50. Monroe, J. G., S. Haldar, M. B. Prystowsky, and P. Lammie. 1988. Lymphokine regulation of inflammatory processes: interleukin-4 stimulates fibroblast proliferation. Clin. Immunol. Immunopathol. 49:292.
51. Mueller, R., T. Krahl, and N. Sarvetnick. 1997. Tissue-specific expression of interleukin-4 induces extracellular matrix accumulation and extravasation of B cells. Lab. Invest. 76:117.
52. Lukacs, N. W., C. L. Addison, J. Gauldie, F. Graham, K. Simpson, R. M. Strieter, K. Warmington, S. W. Chensue, and S. L. Kunkel. 1997. Transgene-induced production of IL-4 alters the development and collagen expression of T helper cell 1-type pulmonary granulomas. J. Immunol. 158:4478.
53. David, A., J. Chetritt, H. Coupel-Clauce, L. Tesson, A. Cassard, G. Blancho, B. Charreau, J. Sigalla, F. Buzelin, B. Le Mauff, et al. 1997. Adenovirus-mediated gene transfer in rat liver of interleukin 4 but not interleukin 10 produces severe acute hepatitis. Cytokine 9:818.
54. Doucet, C., D. Brouty-Boye, C. Pottin-Clemenceau, G. W. Canonica, C. Jasmin, and B. Azzarone. 1998. Interleukin (IL) 4 and IL-13 act on human lung fibroblasts: implication in asthma J. Clin. Invest. 101:2129.
55. Jasin, H. E. 1985. Autoantibody specificities of immune complexes sequestered in articular cartilage of patients with rheumatoid arthritis and osteoarthritis. Arthritis Rheum. 28:241.
56. Veto, A. A., M. Mannila, E. Zatavain-Rios, and M. H. Weber. 1990. Immune deposits in articular cartilage of patients with rheumatoid arthritis have a granular pattern not seen in osteoarthritis. Rheumatol. Int. 10:13.
57. Ugai, K., H. Ishikawa, K. Hirohata, and H. Shirane. 1983. Interaction of polymorphonuclear leukocytes with immune complexes trapped in rheumatoid articular cartilage. Arthritis Rheum. 26:1434.
58. Schalkwijk, J., W. B. Van den Berg, L. A. B. Joosten, and L. B. A. Van de Putte. 1987. Elastase secreted by activated polymorphonuclear leukocytes causes chondrocyte damage and matrix degradation in intact articular cartilage: escape from inactivation by α-1-proteinase inhibitor. Br. J. Exp. Pathol. 68:81.
59. Campbell, E. J., E. K. Silverman, and M. A. Campbell. 1989. Elaslase and cathepsin G of human monocytes: quantification of cellular content, release in response to stimuli, and heterogeneity in elastase-mediated proteolytic activity. J. Immunol. 143:2961.
60. Kowanko, I. C., and A. Ferrante. 1996. Adhesion and TNF priming in neutrophil-mediated cartilage damage. Clin. Immunol. Immunopathol. 79:36.
61. Van Lent, P. L. E. M., L. Van den Bersselaar, L. B. A. Van de Putte, and W. B. Van den Berg. 1990. Immobilization aggravates cartilage damage during antigen-induced arthritis in mice: attachment of polymorphonuclear leukocytes to articular cartilage. Am. J. Pathol. 136:1407.